Kyle Mikson
Stock Analyst at Canaccord Genuity
(0.98)
# 3,519
Out of 4,749 analysts
68
Total ratings
28.81%
Success rate
-17.03%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Maintains: Buy | $5 → $7 | $4.10 | +70.73% | 2 | Jan 3, 2025 | |
| NTRA Natera | Maintains: Buy | $165 → $180 | $176.27 | +2.12% | 6 | Jan 3, 2025 | |
| RGEN Repligen | Initiates: Hold | $165 | $167.53 | -1.51% | 1 | Dec 17, 2024 | |
| AKYA Akoya Biosciences | Maintains: Buy | $6 → $3.5 | $2.99 | +17.06% | 3 | Nov 15, 2024 | |
| LUCD Lucid Diagnostics | Maintains: Buy | $3 | $0.92 | +224.71% | 4 | Nov 14, 2024 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $1.5 → $1 | $1.96 | -48.98% | 3 | Nov 13, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $95 → $75 | $56.03 | +33.86% | 9 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Hold | $130 → $145 | $133.01 | +9.01% | 6 | Nov 5, 2024 | |
| CSTL Castle Biosciences | Maintains: Buy | $35 → $42 | $28.22 | +48.83% | 3 | Oct 29, 2024 | |
| TXG 10x Genomics | Maintains: Buy | $32 → $20 | $15.08 | +32.63% | 6 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $3 | $1.60 | +87.50% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $3 → $5 | $0.21 | +2,280.95% | 3 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $38 | $49.94 | -23.91% | 4 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $25 | $9.56 | +161.51% | 4 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.04 | +236.54% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.63 | +220.00% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.67 | +7,254.26% | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $19 | $3.14 | +505.10% | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $0.40 | +37,213.43% | 1 | Jan 29, 2021 |
Exagen
Jan 3, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $4.10
Upside: +70.73%
Natera
Jan 3, 2025
Maintains: Buy
Price Target: $165 → $180
Current: $176.27
Upside: +2.12%
Repligen
Dec 17, 2024
Initiates: Hold
Price Target: $165
Current: $167.53
Upside: -1.51%
Akoya Biosciences
Nov 15, 2024
Maintains: Buy
Price Target: $6 → $3.5
Current: $2.99
Upside: +17.06%
Lucid Diagnostics
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $0.92
Upside: +224.71%
Quantum-Si incorporated
Nov 13, 2024
Maintains: Hold
Price Target: $1.5 → $1
Current: $1.96
Upside: -48.98%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $56.03
Upside: +33.86%
Illumina
Nov 5, 2024
Maintains: Hold
Price Target: $130 → $145
Current: $133.01
Upside: +9.01%
Castle Biosciences
Oct 29, 2024
Maintains: Buy
Price Target: $35 → $42
Current: $28.22
Upside: +48.83%
10x Genomics
Oct 10, 2024
Maintains: Buy
Price Target: $32 → $20
Current: $15.08
Upside: +32.63%
Aug 8, 2024
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.60
Upside: +87.50%
Jul 30, 2024
Maintains: Hold
Price Target: $3 → $5
Current: $0.21
Upside: +2,280.95%
Jun 4, 2024
Maintains: Buy
Price Target: $30 → $38
Current: $49.94
Upside: -23.91%
Apr 29, 2024
Maintains: Buy
Price Target: $32 → $25
Current: $9.56
Upside: +161.51%
Mar 4, 2024
Reiterates: Buy
Price Target: $3.5
Current: $1.04
Upside: +236.54%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.63
Upside: +220.00%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.67
Upside: +7,254.26%
Jan 29, 2021
Initiates: Overweight
Price Target: $19
Current: $3.14
Upside: +505.10%
Jan 29, 2021
Initiates: Overweight
Price Target: $150
Current: $0.40
Upside: +37,213.43%